Capricor Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,228.5% | – | – | – | – | – | – | – | -620.6% | – | – | |
| – | +0.0% | -58.5% | – | – | – | – | – | – | +319.8% | +40.9% | -91.9% | -41.9% | -16.7% | +330.4% | +55.6% | +164.6% | +13.4% | +14.7% | +9.3% | +9.1% | -16.3% | +70.8% | +117.0% | +100.5% | +33.3% | +32.5% | |
| – | – | – | – | – | – | – | – | – | -1.6% | -26.0% | -50.0% | -28.2% | -61.2% | -15.7% | +88.5% | +216.6% | +24.7% | -12.8% | +0.9% | -59.4% | +178.6% | +51.9% | +50.3% | +65.8% | +32.1% | +76.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -129.2% | – | -77.2% | +216.6% | +120.1% | -50.6% | +0.9% | -59.2% | +177.5% | +42.6% | +61.3% | – | – | – | |
| – | – | -35.1% | -86.2% | -468.0% | – | -58.8% | +45.4% | +56,428.6% | -176.0% | – | – | -223.3% | – | – | +1,132.6% | -94.6% | -263.8% | – | – | – | – | -87.9% | +15,666.7% | -140.9% | – | – | |
| – | – | – | – | – | – | – | – | – | -67.9% | -60.4% | -94.0% | -9.9% | +575.8% | +714.3% | +70.5% | -18.9% | +28.1% | -83.4% | +883.3% | +73.0% | +0.0% | +118.5% | +180.8% | -39.1% | -24.8% | +88.7% | |
| – | – | – | – | – | – | – | – | – | -67.9% | -63.1% | -93.6% | -9.9% | +217,187.3% | – | -96.3% | -5,871.9% | -36.2% | – | -6.2% | -164.3% | – | -122.0% | +2,831.8% | – | -2,374.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -48.0% | -100.0% | – | +341,201.3% | -15.8% | -20.2% | -38.1% | -100.0% | – | -38.8% | -75.9% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +32.5% | -8.7% | +0.0% | -89.5% | -36.4% | +0.0% | +0.0% | -100.0% | – | – | – | – | |
| – | – | – | – | +54.2% | -31.3% | +16.0% | +217.3% | +35,825.9% | – | – | +29.1% | -48.9% | -48.4% | +228.7% | +32.6% | +216.8% | +13.0% | -37.8% | -40.8% | +33.9% | +263.7% | -39.4% | -75.9% | +424.8% | +497.2% | +62.9% | |
| – | – | -198.8% | – | – | -142.1% | – | – | – | -175.5% | – | – | -1,255.4% | – | – | +304.3% | -139.1% | – | – | -200.3% | – | – | -92.3% | -1,239.1% | – | -166.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,520.6% | – | – | – | – | – | – | – | -1,875.6% | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.